Strand Life Sciences expands sequencing facility
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
This product will be launched through Granules Consumer Health (GCH) division
The company has submitted marketing authorization applications for mRNA-1345 with the European Medicines Agency (EMA), Swissmedic in Switzerland, and the Therapeutic Goods Administration (TGA) in Australia
Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent
New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia
This innovative product eliminates two manufacturing steps and simplifies equipment setup
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn’s disease and other autoimmune conditions
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Subscribe To Our Newsletter & Stay Updated